Edward C. Saltzman
Board member since 2019
Edward Saltzman (born 1955) has more than 30 years of experience in the biopharmaceutical industry. He currently serves as chairman and member of management of Cello Health BioConsulting, previously Defined Health, after having led the sale of Defined Health to Cello Health in 2017. Cello Health BioConsulting is a leading strategic business development advisory firm serving senior executives in pharma, biotech and investment. Prior to the acquisition, Saltzman founded and spent 24 years as president of Defined Health. He also currently serves as investment advisor to Israel Biotech Fund and previously served as a board member for Vidac Pharmaceuticals Ltd. Saltzman earned his degree from New York University.
Saltzman is independent in relation to both Saniona and its management as well as major shareholders. He holds 4,200 shares, 4,000 warrants in the warrant program 2019/2023 and 77,000 warrants in the warrant program 2020/2024.